Salarius Pharmaceuticals, Inc. (DCOY)
NASDAQ · Healthcare
Salarius Pharmaceuticals, Inc. Income Statement 2015–2022
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenue | 0 | 1.8M | 5.2M | 3.5M | 2.0M | 1.3M | 1.0M | 0 |
| Gross Profit | — | — | — | — | 1.5M | 767,969 | 347,916 | 0 |
| Profitability | ||||||||
| Operating Income | -31.8M | -12.8M | -7.8M | -8.3M | -1.7M | -34.7M | -39.9M | -29.2M |
| EBITDA | -31.8M | -12.8M | -7.8M | -8.1M | -1.7M | — | — | — |
| Net Income | -31.6M | -12.8M | -7.4M | -6.9M | -1.7M | -34.4M | -39.5M | -29.1M |
| Per Share Data | ||||||||
| EPS (diluted) | $-14.88 | $-7.72 | $-0.50 | — | — | — | — | — |
| Shares Outstanding (dil.) | 2M | 2M | 16M | 5M | 2M | 18M | 17M | 16M |
Salarius Pharmaceuticals, Inc. Income Statement — FAQ
Salarius Pharmaceuticals, Inc. (DCOY) income statement over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DCOY's income statement history?
The chart and table above show Salarius Pharmaceuticals, Inc.'s income statement by year and by quarter, including the growth rate.